Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

[Response to therapy in multiple drug resistant tuberculosis patients].

García de la Osa Mde L, García Silvera E, Solano Leal M, Milanés Virelles MT.

Rev Cubana Med Trop. 2012 May-Aug;64(2):153-62. Spanish.

PMID:
23444634
2.

Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.

Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.

Am J Ther. 2011 Sep;18(5):343-9. doi: 10.1097/MJT.0b013e3181dd60ec.

PMID:
20535008
3.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
4.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
5.

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.

Ann Intern Med. 2006 May 2;144(9):650-9.

PMID:
16670134
6.

[Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].

Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.

Kekkaku. 2001 Dec;76(12):723-8. Japanese.

PMID:
11806128
7.

Multidrug-resistant tuberculosis: response to treatment.

Saenghirunvattana S, Charoenpan P, Vathesatogkit P, Kiatboonsri S, Aeursudkij B.

J Med Assoc Thai. 1996 Sep;79(9):601-3.

PMID:
8996991
8.
9.

Treatment of multidrug-resistant tuberculosis in Thailand.

Maranetra KN.

Chemotherapy. 1996;42 Suppl 3:10-5; discussion 30-3. Review.

PMID:
8980862
10.

Multidrug-resistant tuberculosis in patients without HIV infection.

Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, el-Sadr W, Blum S, Gagliardi A, Salomon N, Turett G.

N Engl J Med. 1995 Oct 5;333(14):907-11.

PMID:
7666876
11.

Cost-effectiveness of treating multidrug-resistant tuberculosis.

Resch SC, Salomon JA, Murray M, Weinstein MC.

PLoS Med. 2006 Jul;3(7):e241.

12.

A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.

Tsai MS, Chong IW, Hwang JJ, Wang TH, Huang MS.

Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):136-9.

PMID:
15272756
13.

[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].

Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):179-83. Chinese.

PMID:
19565883
14.

Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.

Man MA, Nicolau D.

Eur J Cardiothorac Surg. 2012 Jul;42(1):e9-12. doi: 10.1093/ejcts/ezs215. Epub 2012 Apr 24.

PMID:
22531273
15.

[Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].

Ogawara M, Sakatani M.

Kekkaku. 1998 Nov;73(11):673-7. Japanese.

PMID:
9866930
16.

[Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].

Wang GJ, Xu JY, Wang GB, Zhen XA, Gao SY, Du CM.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Aug;29(8):527-30. Chinese.

PMID:
17074265
17.

The treatment of multidrug-resistant tuberculosis in Turkey.

Tahaoğlu K, Törün T, Sevim T, Ataç G, Kir A, Karasulu L, Ozmen I, Kapakli N.

N Engl J Med. 2001 Jul 19;345(3):170-4.

18.

Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.

Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Mirsaeidi M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.

Scand J Infect Dis. 2009;41(1):10-3. doi: 10.1080/00365540802298079.

PMID:
19037820
19.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

20.

Predictors of extensively drug-resistant pulmonary tuberculosis.

Kliiman K, Altraja A.

Ann Intern Med. 2009 Jun 2;150(11):766-75.

PMID:
19487711

Supplemental Content

Support Center